• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Industrials·EXENS.PA
Share

Exosens Stocks

€ 60.6Last Updated 12.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

€ 3.59B

€ 60.6
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of EXENS.PA is 63 and suggests 2% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

13.06.2026 00:30

Nebius, AI and space: five new companies will join the Nasdaq-100. Is it too late to buy them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026